Skip to content
OpenCapital
Get started

Collegium Pharmaceutical, Inc. COLL Segment — Medical expenses

Similar metrics at other companies

Alignment Healthcare logo
ALHCReportable Segment — Medical expenses
$1.09B+32.9%
Gentherm logo
THRMMedical Segments — Other Expenses
$6.19M+16.5%
Rhythm Pharmaceuticals, Inc. logo
RYTMSingle reportable segment — Commercial & medical affairs
$20.26M+52.9%
Mirion Technologies logo
MIRMedical Segment — Other segment items
$38.9M+4.0%
Mirum Pharmaceuticals, Inc. logo
MIRMReportable Segment — Commercialization and Medical Affairs expenses (excluding stock-based compensation)
$44.22M+23.6%
Avalo Therapeutics logo
AVTXReportable Segment — Clinical expenses
$5.6M+45.5%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0×0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept coll:MedicalExpenses.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s segment — medical expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s segment — medical expenses?
Collegium Pharmaceutical, Inc. (COLL) reported segment — medical expenses of $7.15M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s segment — medical expenses changed year-over-year?
Collegium Pharmaceutical, Inc.'s segment — medical expenses decreased by 11.0% year-over-year, from $8.03M to $7.15M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — medical expenses?
Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s segment — medical expenses has grown at a 20.5% compound annual growth rate (CAGR), from $16.99M to $29.75M.
What does segment — medical expenses mean?
Includes costs associated with medical affairs, clinical support, and scientific communication activities that educate healthcare providers on product safety and efficacy. These expenses are vital for maintaining the clinical credibility and regulatory compliance of the product portfolio.